Effect of genetic variants related to lipid metabolism as risk factors for cholelithiasis after bariatric surgery in Brazilian population

Obesity Surgery

Volumn 22, Issue 4, 2012, Pages 623-633

  Pinheiro, Sidney ^a   Pinhel, Marcela A S ^a   Nakazone, Marcelo A ^a   Pinheiro, Anielli ^a   Amorim, Gisele F S ^a   Florim, Greiciane M S ^a   Mazeti, Camila M ^a   Gregório, Michele L ^a   Moschetta, Marina G ^a   Brito, Gilberto B ^b   Brienze, Sérgio L A ^b   Nonino, Carla B ^c   Brandão, Antonio C ^a   Souza, Dorotéia R S ^a  

^a São José do Rio Preto Medical School   (Brazil)

^b Sao Jose do Rio Preto Medical School   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

APOE; Bariatric surgery; CETP; Cholelithiasis; Genetic polymorphisms

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; APOLIPOPROTEIN E GENE; ARTICLE; BARIATRIC SURGERY; BODY MASS; BRAZIL; CASE CONTROL STUDY; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTER TRANSFER PROTEIN GENE; FEMALE; GALLSTONE; GASTROPLASTY; GENE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; ROUX Y ANASTOMOSIS; SURGICAL RISK; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADOLESCENT; FOLLOW UP; GENE FREQUENCY; GENETICS; METABOLISM; MIDDLE AGED; MORBID OBESITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STATISTICAL MODEL; STOMACH BYPASS;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS E; BODY MASS INDEX; BRAZIL; CASE-CONTROL STUDIES; CHOLELITHIASIS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY, MORBID; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; YOUNG ADULT;

EID: 84861818954     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0590-7     Document Type: Article

References (55)

1. Garrett JR, McNolty LA. Bariatric surgery and the social character of the obesity epidemic. Am J Bioeth. 2010;10:20-2.
2. Geloneze B, Mancini MC, Coutinho W. Obesity: knowledge, care, and commitment, but not yet cure. Arq Bras Endocrinol Metab 53:117-119
3. Mohan S, Tan J, Gorantla S, et al. (2011) Early improvement in albuminuria in non-diabetic patients after Roux-en-Y bariatric surgery. Obes Surg (in press)
4. Buchwald H, Williams SE. Bariatric surgery world wide 2003. Obes Surg. 2004;14:1157-64. (Pubitemid 39458587)
5. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010;39(2):157-69. vii.
6. Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2011. Epub ahead of print.
7. Sociedade Brasileira de endocrinologia e Metabologia. Obesidade Tratamento. Project Diretrizes 2006. (www.endocrino.org.br).
8. Malherbe V, Badaoui A, Huybrecht H, et al. Management of common bile duct stone late after laparoscopic Roux-en-Y gastric bypass for obesity. Acta Chir Belg. 2009;109(6):820-3.
9. Bessesen DH. Update on obesity. J Clin Endocrinol Metab. 2008;93:2027-34. (Pubitemid 351831511)
10. Surgeman HJ, Brewer WH, Shiffman ML. A multicenter, placebo controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstones formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91-7.
11. Wudel LJ, Wright JK, Debelak JP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102:50-6.
12. Wattchow DA, Hall JC, Whiting MJ, et al. Prevalence and treatment of gallstones after gastric bypass surgery for morbid obesity. Br Med J. 1983;286:763. (Pubitemid 13147686)
13. O'Brien PE, Dixon JB. A rational approach to cholelithiasis in bariatric surgery: its application to the laparoscopically placed adjustable gastric band. Arch Surg. 2003;138:908-12. (Pubitemid 36960955)
14. Dittrick GW, Thompson JS, Campos D, et al. Gallbladder pathology in morbid obesity. Obes Surg. 2005;15:238-42. (Pubitemid 40316010)
15. Smelt AHM. Triglycerides and gallstone formation. Clinica Chimica Acta. 2010;411:1625-31.
16. Torres OMJ, Barbosa ES, Pantoja PB, et al. Prevalência ultra-sonográfica de litíase biliar empacientes ambulatoriais. Rev Col Bras Cir. 2005;32:47-9.
17. Taha MIA, Freitas Jr WR, Puglia CR, et al. Fatores preditivos de colelitíase em obesos mórbidos após gastroplastia em y de Roux. Rev Assoc Med Bras. 2006;52(6):430-4.
18. Desbeaux A, Hec F, Andrieux S, et al. Risk of biliary complications in bariatric surgery. J Visc Surg. 2010;147(4):e217-20.
19. Sari R, Balci MK, Coban E, et al. Sonographic evaluation of gallbladder volume and ejection fraction in obese women without gallstones. J Clin Ultrasound. 2003;31:352-7. (Pubitemid 37010931)
20. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology. 1990;99:843-9. (Pubitemid 20243380)
21. Juvonen T, Kervinen K, Kairaluoma MI, et al. Gallstone cholesterol content is related to apolipoprotein E polymorphism.Gastroenterology. 1993;104(6):1806-13. (Pubitemid 23235475)
22. Sorli JV, Corella D, Frances F, et al. The effect of the APOE polymorphism on HDLCconcentrations depends on the cholesterol ester transfer protein gene variation in a Southern European population. Clin Chim Acta. 2006;366:196-203. (Pubitemid 43330983)
23. Junyent M, Lee YC, Smith CE, et al. The effect of a novel intergenic polymorphism (rs11774572) on HDL-cholesterol concentrations depends on TaqIB polymorphism in the cholesterol ester transfer protein gene. Nutr Metab Cardiovasc Dis. 2010;20(1):34-40. Epub 2009 Apr 11.
24. Ruan X, Ma L, Wang S, et al. Association of two CETP polymorphisms with HDL levels in the Chinese obese population. Obesity. 2009;17(12):2196-201.
25. Ordovas JM. Genetic polymorphisms and activity of cholesterol ester transfer protein (CETP): should we be measuring them? Clin Chem Lab Med. 2000;38(10):945-9.
26. Ruan X, Ma L, Wang S, et al. TAQIB and I405V polymorphisms of CETP are moderately associated with obesity risk in the Chinese adult population. Acta Diabetol. 2010;47(3):217-24.
27. Waterworth DM, Ricketts SL, Song K, et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010;30(11):2264-76.
28. Utermann G, Hees M, Steinmetz A. Polymorphism of lipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977;269:604-7.
29. Zannis VI, Just PW, Breslow JL. Human apolipoprotein E isoprotein subclasses are genetically determined. AmJ Hum Genet. 1981;33:11-34.
30. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and artherosclerosis. Artherosclerosis. 1988;8:1-21.
31. Addante F, Sancarlo D, Copetti M, et al. Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients. Rejuvenation Res. 2011;14(2):111-8.
32. Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507-37.
33. Grigor'eva IN, Nikitenko TM, Shakhtshneǐder EV, et al. APOE gene polimorphism and lithogenicity of the bile in the women with cholelithiasis. Eksp Klin Gastroenterol. 2009;(8):56-60.
34. Pena SD, Bastos-Rodrigues L, Pimenta JR, et al. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res. 2009;42 (10):870-6.
35. Sociedade Brasileira de Cirurgia Bariátrica e Metabólica- (http://www.sbcbm.org.br).
36. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42 (6):1206-52. (Pubitemid 37553153)
37. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patientndocrine Practice (AACE). 2008:14;(Suppl 1).
38. Salazar LA, Hirata MH, Cavalli SA, et al. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem. 1998;44:1748-50.
39. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med. 1998;338:86-93.
40. Hixson JP, Vernier DT. Restriction isotyping of human apoliprotein E by gene amplification and clevage with Hhal. J L Res. 1990;31:545-8. (Pubitemid 20107994)
41. Sociedade Brasileira de Cardiologia. IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose. Arquivos Brasileiros de Cardiologia. 2007;Volume 88, Suplemento I.
42. DixitM, Choudhuri G, Mittal B. Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: a case-control study. Hepatol Res. 2006;36:61-9. (Pubitemid 44309282)
43. Abu Abeid S, Szold A, Gavert N, et al. Apolipoprotein-E genotype and the risk of developing cholelithiasis following bariatric surgery: a clue to prevention of routine prophylactic cholecystectomy. Obes Surg. 2002;12:354-7. (Pubitemid 34621029)
44. Xiao C, Watanabe T, Zhang Y, et al. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia. Circ Res. 2008;103(2):159-66.
45. Portincasa P, van Erpecum KJ, van De Meeberg PC, et al. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology. 1996;24:580-7. (Pubitemid 26296001)
46. Bertomeu A, Ros E, Zambo D, et al. (1996) Apolipoprotein E polymorphism and gallstones. Gastroenterology 111: 1603-1610. (Pubitemid 26404225)
47. Ko CW, Beresford SA, Alderman B, et al. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology. 2000;31(1):18-23. (Pubitemid 30033683)
48. Hasegawa K, Terada S, Kubota K, et al. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone. Am J Gastroenterol. 2003;98:1605-9. (Pubitemid 36875355)
49. Moon JH, Cho YD, Hong SJ, et al. Is apolipoprotein E polymorphism related to bile duct stones? Gastroenterology. 1998;114:A532. Abstract.
50. Huang Y, Wu Y, Liu R, et al. Differential effect of ATP binding cassette transporter A1 R219K and cholesteryl ester transfer protein TaqIB genotypes on HDLClevels in overweight/obese and non-obese Chinese subjects. Acta Cardiol. 2011;66(2):231-7.
51. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem. 1995;64:235-57.
52. Méndez-Sánchez N, TanimotoMA, Cobos E, et al. Cholesterolosis is not associated with high cholesterol levels in patients with and without gallstone disease. J Clin Gastroenterol. 1997;25(3):518-21. (Pubitemid 27528149)
53. Hayes KC, Khosla P, Pronczuk A. Diet-induced type IV-like hyperlipidemia and increased body weight are associatedwith cholesterol gallstones in hamsters. Lipids. 1991;26(9):729-35.
54. Zhao JC, Xiao LJ, Zhu H, et al. Changes of lipid metabolism in plasma, liver and bile during cholesterol gallstone formation in rabbit model. World J Gastroenterol. 1998;4(4):337-9. (Pubitemid 128620185)
55. Venneman NG, vanBerge-Henegouwen GP, Portincasa P, et al. Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy. J Hepatol. 2001;35(1):10-6. (Pubitemid 32646219)